Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes ...

The product is priced at 95% below the brand-name cost. Ease of adoption. The product is FDA-designated as interchangeable and supported by innovative prescriber and patient engagement programs to ...

AbbVie recently reported record 2025 results and outlined a stronger 2026 outlook, while advancing key immunology assets and completing the VOLITE skin quality aesthetics trial to bolster its ...

As a physician, I hear daily from patients across Oregon who struggle to access lifesaving addiction care. The Oregon Senate Committee on Early Childhood and Behavioral Health recently held a public ...

Add Yahoo as a preferred source to see more of our stories on Google. The work at a syringe exchange center, like the one housed at the Damien Center on Indianapolis' east side, doesn't begin and end ...

The work at a syringe exchange center, like the one housed at the Damien Center on Indianapolis' east side, doesn't begin and end with handing out sterile needles. It begins with some reassurance. "We ...

MedImpact expands access and affordability across healthcare with a low-cost alternative to one of the most prescribed and expensive biologics in the US MedImpact Holdings, Inc. today announced the ...